UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96

Journal of clinical oncology, 2008-04, Vol.26 (11), p.1843-1849

2008

Link zum Volltext

Verfügbarkeit prüfen

Copy number profiling of adult relapsed B‐cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms

Genes chromosomes & cancer, 2017-11, Vol.56 (11), p.810-820

2017

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features

Epigenetics, 2018-01, Vol.13 (1), p.8-18

2018

Link zum Volltext

Verfügbarkeit prüfen

Incidence and prognostic significance of nephrotoxicity in patients receiving eshap as salvage therapy for lymphoma

Leukemia research, 2017-07, Vol.58, p.98-101

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+ cell count to guide pre-emptive or immediate rescue mobilization

Cytotherapy (Oxford, England), 2012-08, Vol.14 (7), p.823-829

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit : A single-center experience

International journal of hematology, 2007-04, Vol.85 (3), p.195-202

2007

Link zum Volltext

Verfügbarkeit prüfen

Copy Number Alterations in patients with mature B (Burkitt-type) acute lymphoblastic leukaemia treated with specific immunochemotherapy

Clinical lymphoma, myeloma and leukemia, 2015-06, Vol.15, p.S174-S174

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Copy Number Alterations in B-lineage Adult Acute Lymphoblastic Leukemia Patients Enrolled in Risk-adapted Protocols from the PETHEMA Group

Clinical lymphoma, myeloma and leukemia, 2015-06, Vol.15, p.S173-S174

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial

Journal of clinical oncology, 2014-05, Vol.32 (15), p.1595-1604

2014

Link zum Volltext

Verfügbarkeit prüfen

Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy

International journal of hematology, 2007-11, Vol.86 (4), p.337-342

2007

Link zum Volltext

Verfügbarkeit prüfen

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

Haematologica (Roma), 2010-04, Vol.95 (4), p.589-596

2010

Link zum Volltext

Verfügbarkeit prüfen

Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related Lymphomas

Clinical infectious diseases, 2019-02, Vol.68 (5), p.834-843

2019

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and prognostic contribution of targeted NGS in patients with triple‐negative myeloproliferative neoplasms

American journal of hematology, 2019-10, Vol.94 (10), p.E264-E267

2019

Link zum Volltext

Verfügbarkeit prüfen

HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era

AIDS (London), 2015-04, Vol.29 (7), p.811-818

2015

Link zum Volltext

Verfügbarkeit prüfen

HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma

AIDS (London), 2017-06, Vol.31 (10), p.1445-1449

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine

Oncotarget, 2018-04, Vol.9 (27), p.19342-19355

2018

Link zum Volltext

Verfügbarkeit prüfen

Consistency of the Moreau CLL score

Journal of clinical laboratory analysis, 2018-06, Vol.32 (5), p.e22376-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Blood, 2017-12, Vol.130, p.4004-4004

2017

Link zum Volltext

Verfügbarkeit prüfen

Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) in Adult Patients with High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Acute Lymphoblastic Leukemia (ALL) According to Their Minimal Residual Disease (MRD). Final Results of the Pethema ALL-HR-11 Trial

Blood, 2019-11, Vol.134 (Supplement_1), p.826-826

2019

Link zum Volltext

Verfügbarkeit prüfen

Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain

Medicina clínica, 2008-06, Vol.131 (1), p.5-9

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features

Oncotarget, 2016-08, Vol.7 (35), p.57021-57035

2016

Link zum Volltext

Verfügbarkeit prüfen

Adoption of Bio/Data Collagen for the assessment of platelet function with the Multiplate® Analyzer

Thrombosis research, 2018-01, Vol.161, p.33-35

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(189)
Berichte
(5)

Sprache

Englisch
(166)
Spanisch
(30)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(112)
Life Sciences & Biomedicine
(106)
Science & Technology
(106)
Male
(93)
Female
(92)
Adult
(75)
Middle Aged
(73)
Hematology
(62)
Aged
(47)
Prognosis
(47)
Oncology
(40)
Biological And Medical Sciences
(39)
Medical Sciences
(39)
Adolescent
(35)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Treatment Outcome
(26)
Hematologic And Hematopoietic Diseases
(25)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)
Young Adult
(21)
Acute Lymphoblastic Leukemia
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96

Copy number profiling of adult relapsed B‐cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms

DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features

Incidence and prognostic significance of nephrotoxicity in patients receiving eshap as salvage therapy for lymphoma

Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+ cell count to guide pre-emptive or immediate rescue mobilization

Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit : A single-center experience

Copy Number Alterations in patients with mature B (Burkitt-type) acute lymphoblastic leukaemia treated with specific immunochemotherapy

Prognostic Significance of Copy Number Alterations in B-lineage Adult Acute Lymphoblastic Leukemia Patients Enrolled in Risk-adapted Protocols from the PETHEMA Group

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial

Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related Lymphomas

Diagnostic and prognostic contribution of targeted NGS in patients with triple‐negative myeloproliferative neoplasms

Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols

HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era

HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma

Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine

Consistency of the Moreau CLL score

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Molecular profiling refines minimal residual disease‐based prognostic assessment in adults with Philadelphia chromosome‐negative B‐cell precursor acute lymphoblastic leukemia

Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain

Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features

Adoption of Bio/Data Collagen for the assessment of platelet function with the Multiplate® Analyzer

Suchergebnisse filtern